Cancer mortality and insulin glargine

J Diabetes. 2009 Sep;1(3):131-3. doi: 10.1111/j.1753-0407.2009.00038.x. Epub 2009 Jul 2.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Databases, Factual
  • Diabetes Complications / epidemiology
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Insulin / adverse effects
  • Insulin / analogs & derivatives*
  • Insulin Glargine
  • Insulin Resistance
  • Insulin, Long-Acting
  • Neoplasms / etiology
  • Neoplasms / mortality*

Substances

  • Hypoglycemic Agents
  • Insulin
  • Insulin, Long-Acting
  • Insulin Glargine